ClinicalTrials.gg
RecruitingNCT07878546Updated Oct 16, 2026

Ligasure Versus Conventional Diathermy in Hemorrhoidectomy

An interventional study of ligasure in Hemorrhoids, sponsored by Sohag University. Recruiting at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by Sohag University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Sep 2026; still recruiting 1 month later.
Updated Oct 16, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Sex
All
01

Study summary

comparison study in the treatment of hemorrhoid between ligasure device and the conventional diathermy

Read the detailed description

comparison study between ligasure and conventional diathermy in hemorroidectomy regarding the duration of postoperatine pain, intraoperative and postoperative bleeding, early return to work, postoperative itching, and return to the normal life.

this prospective study will be conducted on 40 patients diagnosed with hemorroidectomy including all patients with symptomatic hemorrhoid comparing two groups the first group undergo hemorrhoidectomy using ligasure the second group using conventional diathermy

02

Conditions studied

  • Hemorrhoids

Browse trials for

Keywords

  • ligasure
03

In context

Hemorrhoids

226 studies on the registry are indexed under Hemorrhoids; 66 are open to participants now.

This study's planned enrollment of 40 is below the median of 97 across 173 interventional studies indexed under Hemorrhoids.

Browse Hemorrhoids studies →

Lead sponsor

Sohag University is the lead sponsor of 1,218 studies on the registry; 627 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • all patients with symptomatic hemorrhoid require hemorrhoidectomy

Exclusion criteria

Exclusion Criteria:

  • presence of other rectal or anal pathology, patients with recurrent hemorrhoid, patients with other medcal or anasthetic contraindications
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    ligasure

    hemorrhoid treatment using ligasure

    Device: ligasure

  • Active comparator
    conventional diathermy

    hemorrhoid treatment using conventional diathermy

    Device: ligasure

Interventions

  • Deviceligasure

    using the ligasure devive in the excision of piles

06

What researchers measure

Primary outcomes

  1. bleeding

    occurence of bleeding after operation

    Time frame: 2 day postoperative

Secondary outcomes

  1. hospital stay

    hospital stay after operation

    Time frame: 4 days

  2. post operative itching

    itching occured after operation

    Time frame: 2 weeks

07

Study locations

1 of 1 sites recruiting
  • Mohamd Refaey Mohamed
    Sohag, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07878546
Lead sponsor
Sohag University
Responsible party
Mohamed Refaay Mohamed (Resident physician, department of general surgery Sohag university hospitals, Sohag University) — Principal investigator
First posted
Oct 16, 2026
Start date
Sep 25, 2026
Primary completion
Mar 26, 2027 (estimated)
Completion
Apr 25, 2027 (estimated)
Last update
Oct 16, 2026

Study contacts

mohamed refaey, master
Contact
drmido2025@gmail.com
01126544564
mphamed refaey, master
Contact
01066116954

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion